Skip to content

Indocyanine Green and Rectosigmoid Endometriosis

Intraoperative Assessment of Bowel Perfusion Through Indocyanine Green in Women With Rectosigmoid Endometriosis and Its Correlation With Clinical and Surgical Data

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03532074
Acronym
vincendo
Enrollment
40
Registered
2018-05-22
Start date
2018-05-28
Completion date
2019-11-30
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Endometriosis, Endometriosis, Rectum

Brief summary

Indocyanine green is a fluorescent dye used for the intraoperative evaluation of tissue perfusion. The aim of this study is to evaluate a possible correlation between rectosigmoid vascularization and surgical and clinical data including pre and post-operative bowel symptoms in patients needing surgery for rectosigmoid endometriosis.

Detailed description

Patients with symptomatic rectosigmoid endometriosis requiring laparoscopic surgery are included in the study. Before surgery, bowel symptoms are assessed using validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index). Indocyanine green is administered through peripheral line. A near-infrared (NIR) camera-head enables real-time direct visualization of bowel perfusion before and after the removal of the rectosigmoid nodule. Rectosigmoid tract perfusion is assessed before and after the removal of the nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used. After complete removal of rectosigmoid nodule, the post-operative follow-up will be the same as usual after intestinal endometriosis surgery. Postoperative bowel symptoms are evaluated using the same questionnaires.

Interventions

DIAGNOSTIC_TESTassessment of bowel symptoms before surgery

validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) are filled in by patients with rectosigmoid endometriosis before surgery

DIAGNOSTIC_TESTassessment of rectosigmoid during laparoscopy

indocyanine green (0.25 mg/kg) is administered through peripheral line. A near-infrared camera-head (KARL STORZ Gesellschaft mit beschränkter Haftung & Co., Tuttlingen, Germany) is used to visualize bowel perfusion before and after the removal of the rectosigmoid nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used

DIAGNOSTIC_TESTfollow up and assessment of bowel symptoms after surgery

validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) are filled in by patients with rectosigmoid endometriosis after surgery

DIAGNOSTIC_TESTassessment of rectosigmoid perfusion during robot-assisted laparoscopy

indocyanine green (0.25 mg/kg) is administered through peripheral line. The robotic Firefly imaging system (daVinciXi surgical platform; Intuitive Surgical, Sunnyvale, CA) is used to visualize bowel perfusion before and after the removal of the rectosigmoid nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

OPEN

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of deep endometriosis based on clinical and transvaginal/transabdominal ultrasound examinations and, when necessary, magnetic resonance * Patients with indication for removal of endometriosic lesions by laparoscopic surgery * Obtaining Informed Consent

Exclusion criteria

* Known or suspected allergy to iodine * Previous rectal surgery * History of active pelvic infection * Intra-abdominal or pelvic malignancy * Pelvic radiation therapy * Hyperthyroidism * Liver dysfunction * Serum creatinine \> 2.0 mg/dL

Design outcomes

Primary

MeasureTime frameDescription
correlation between bowel symptoms and rectosigmoid perfusion before the nodule removalintraoperativecomparison between bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) and rectosigmoid perfusion, measured before the nodule removal using indocyanine green and a scale from 0 to 4.

Secondary

MeasureTime frameDescription
correlation between bowel symptoms and rectosigmoid perfusion after the nodule removalup to three months after surgerycomparison between rectosigmoid perfusion, measured after the nodule removal using indocyanine green and a scale from 0 to 4, and bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index).
correlation between bowel perfusion after rectal surgery and post-operative complicationsup to three months after surgery; from date of surgery until the date of first documented complication, assessed up to 3 monthsassessment of rectosigmoid perfusion, through indocyanine green and a scale from 0 to 4, and complications (rectovaginal fistula, dehiscence of anastomotic suture, rectal bleeding, rectosigmoid perforation, rectosigmoid stenosis), using Clavien-Dindo Classification.

Countries

Italy

Contacts

Primary ContactDIEGO RAIMONDO
DIE.RAIMONDO@GMAIL.COM00390512144385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026